Assignee
ONCOPEPTIDES AB
SE·11 granted patents·8 pending applications·28 citations·filing 2001–2025
Top patents by PatentIndex Score
19 records- 0194US11896668B2Lyophilized preparation of cytotoxic dipeptidesONCOPEPTIDES AB·Filed 2022·Granted Feb 13, 2024·2 cites·21 claims
- 0289US10869928B2Lyophilized preparation of cytotoxic dipeptidesONCOPEPTIDES AB·Filed 2019·Granted Dec 22, 2020·3 cites·16 claims
- 0389US10322182B2Lyophilized preparation of cytotoxic dipeptidesONCOPEPTIDES AB·Filed 2016·Granted Jun 18, 2019·6 cites·16 claims
- 0488US10543274B2Lyophilized preparation of cytotoxic dipeptidesONCOPEPTIDES AB·Filed 2019·Granted Jan 28, 2020·4 cites·21 claims
- 0588US2024358838A1Lyophilized preparation of cytotoxic dipeptidesONCOPEPTIDES AB·Filed 2024·Application pending·0 cites
- 0683US12152087B2Deuterated melflufen compoundsONCOPEPTIDES AB·Filed 2019·Granted Nov 26, 2024·2 cites·17 claims
- 0782US10285946B2Lyophilized preparations of melphalan flufenamideONCOPEPTIDES AB·Filed 2013·Granted May 14, 2019·5 cites·22 claims
- 0880US10285947B2Lyophilized preparations of melphalan flufenamideONCOPEPTIDES AB·Filed 2016·Granted May 14, 2019·3 cites·34 claims
- 0974US11344622B2Lyophilized preparation of cytotoxic dipeptidesONCOPEPTIDES AB·Filed 2020·Granted May 31, 2022·0 cites·21 claims
- 1068US2020009252A1Lyophilized preparation of cytotoxic dipeptidesONCOPEPTIDES AB·Filed 2019·Application pending·0 cites
- 1163US6992207B2Melphalan derivatives and their use as cancer chemotherapeutic drugsONCOPEPTIDES AB·Filed 2001·Granted Jan 31, 2006·3 cites·17 claims
- 1259US2014128462A1Lyophilized preparation of cytotoxic dipeptidesONCOPEPTIDES AB·Filed 2012·Application pending·0 cites
- 1354US2026021067A1Treatment of al amyloidosis with melflufenONCOPEPTIDES AB·Filed 2025·Application pending·0 cites
- 1449US2022047507A1Melflufen dosage regimens for cancerONCOPEPTIDES AB·Filed 2021·Application pending·0 cites
- 1548US12396975B2Treatment of al amyloidosis with melflufenONCOPEPTIDES AB·Filed 2020·Granted Aug 26, 2025·0 cites·19 claims
- 1648US2024316059A1Peptide drug conjugatesONCOPEPTIDES AB·Filed 2022·Application pending·0 cites
- 1743US2024307480A1Melflufen for use in the treatment of multiple myelomaONCOPEPTIDES AB·Filed 2022·Application pending·0 cites
- 1842US2018369141A1Melflufen dosage regimens for cancerONCOPEPTIDES AB·Filed 2016·Application pending·0 cites
- 1928US10287316B2Process for preparation of nitrogen mustard derivativesONCOPEPTIDES AB·Filed 2016·Granted May 14, 2019·0 cites·26 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →